Reata Pharma (RETA)
172.36 +0.04 (+0.02%) 09/26/23 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Mon, Sep 25th, 2023
Results
download Want to compare other data? Select Fields| Symbol | RETA | TGTX | LEGN | ||
| Company | Reata Pharma | Tg Therapeutics | Legend Biotech Corp ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 172.34 | 42.18 | 34.43 | ||
| High | 172.46 | 43.98 | 35.24 | ||
| Low | 172.32 | 41.64 | 34.22 | ||
| Last | 172.36 | 43.86 | 34.43 | ||
| Change | +0.04 | +1.83 | -0.27 | ||
| % Change | +0.02% | +4.35% | -0.78% | ||
| Volume | 1,988,500 | 2,694,000 | 702,900 | ||
| 20-Day Average Volume | 810,510 | 2,804,460 | 1,585,715 | ||
| Previous Close | 172.32 | 42.03 | 34.70 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 38.58 | 32.84 | ||
| 20-Day Raw Stochastic | 97.36% | 99.08% | 85.31% | ||
| 20-Day Relative Strength | 81.56% | 64.84% | 50.66% | ||
| Weighted Alpha | +177.60 | +152.88 | -26.72 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | +15.45% since 04/22/25 | -0.15% since 04/22/25 | ||
| Low | 171.96 on 09/19/23 | 38.47 on 04/23/25 | 33.66 on 04/25/25 | ||
| High | 172.46 on 09/25/23 | 43.98 on 04/29/25 | 35.32 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | +10.04% since 03/28/25 | -1.80% since 03/28/25 | ||
| Low | 168.67 on 09/05/23 | 31.00 on 04/09/25 | 29.27 on 04/09/25 | ||
| High | 172.46 on 09/25/23 | 43.98 on 04/29/25 | 35.32 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | +31.44% since 01/29/25 | -4.63% since 01/29/25 | ||
| Low | 88.80 on 06/27/23 | 28.17 on 02/28/25 | 29.27 on 04/09/25 | ||
| High | 172.46 on 09/25/23 | 43.98 on 04/29/25 | 40.00 on 02/21/25 | ||
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | +70.60% since 10/29/24 | -24.26% since 10/29/24 | ||
| Low | 76.54 on 05/10/23 | 22.92 on 11/04/24 | 29.27 on 04/09/25 | ||
| High | 172.46 on 09/25/23 | 43.98 on 04/29/25 | 47.79 on 11/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 6,673,355 | 6,372,621 | ||
| Shares Outstanding, K | 38,150 | 158,776 | 183,649 | ||
| Annual Sales | 2,220,000 | 329,000,000 | 627,240,000 | ||
| Annual Net Income | -311,900,000 | 23,380,000 | -177,030,000 | ||
| Last Quarter Sales | 22,750,000 | 108,190,000 | 186,520,000 | ||
| Last Quarter Net Income | 193,000,000 | 23,330,000 | 26,280,000 | ||
| 60-Month Beta | 1.42 | 2.14 | 0.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | 0.15 on 03/03/25 | -0.15 on 03/11/25 | ||
| Latest Earnings Date | 11/14/23 | 05/07/25 | 05/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 295.21 | 0.00 | ||